Nitric Oxide Delivery by Neonatal Noninvasive Respiratory Support Devices
- 11 November 2014
- journal article
- Published by SAGE Publications in Respiratory Care
- Vol. 60 (2) , 219-230
Abstract
BACKGROUND: Inhaled nitric oxide (INO) has been used with heated and humidified high-flow nasal cannula (HFNC), nasal CPAP and several forms of noninvasive ventilation (NIV). This study was designed to evaluate the delivered dose of INO, level of NO 2 generation, and effect of net gas delivery (addition of INO to the ventilator circuit − gas removed for sampling) on lung pressure at different NO doses during noninvasive respiratory support. METHODS: An infant lung model was supported with the different noninvasive modes during INO therapy. NO and NO 2 were measured from within the patient circuit of the noninvasive devices and simulated neonatal trachea at several NO levels. Lung pressures were compared with and without INO and at several INO settings. RESULTS: Accuracy of NO delivery was determined to be within the stated accuracy by the manufacturer with nasal CPAP and NIV, but accuracy was compromised during HFNC. INO and NO 2 measured by the INOmax DS IR (Ikaria, Hampton, New Jersey) did not consistently reflect the delivered dose of NO or formation of NO 2 across all types of neonatal noninvasive respiratory support. Tracheal NO 2 levels were < 1.5 ppm with all forms of noninvasive support, except nasal intermittent mandatory ventilation at 40 ppm INO. Lung model mean airway pressures were mildly affected by gas sampling/delivery during combined INO therapy/HFNC at certain flows but remained stable with all other forms of noninvasive support. CONCLUSIONS: Clinicians cannot always assume that the set INO level results in a similar lung dose when using all forms of neonatal noninvasive support. Clinical decisions regarding ways to improve INO delivery may need to include changing settings or placing patients on a different form of noninvasive support. The NO 2 level delivered to the patient could be greater than the value recorded by the INO delivery system.Keywords
This publication has 25 references indexed in Scilit:
- CPAP combined with inhaled nitric oxide for treatment of lung hypoplasia and persistent foetal circulation due to prolonged PPROMEarly Human Development, 2011
- Effect of Lung Recruitment on Pulmonary, Systemic, and Ductal Blood Flow in Preterm InfantsThe Journal of Pediatrics, 2009
- Workplace NO and NO2 during combined treatment of infants with nasal CPAP and NOIntensive Care Medicine, 2006
- Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical VentilationNew England Journal of Medicine, 2006
- A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndromeIntensive Care Medicine, 2005
- Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congential diaphragmatic herniaThe Journal of Pediatrics, 2003
- Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure systemPediatric Anesthesia, 2002
- Oxidation of nitric oxide in a two-stage chemical scrubber using dc corona dischargeJournal of Hazardous Materials, 2000
- Production of nitrogen dioxide during nitric oxide therapy using the Servo Ventilator 300 during volume‐controlled ventilationActa Anaesthesiologica Scandinavica, 1999
- Precise control of nitric oxide concentration in the inspired gas of continuous flow respiratory devicesPediatric Pulmonology, 1996